BMS and cancer centre settle patent exploitation clash
11-04-2023
SCOTUS rejects BMS vs Gilead patent clash
10-11-2022
Bristol Myers can’t convince circuit to overturn $1.2bn ruling
18-01-2022
Fed Circ written description ruling overturns $1.2 billion award
26-08-2021